[{"data":1,"prerenderedAt":25},["ShallowReactive",2],{"project-6bdc73f469ef5fe100da5d634c842ea6":3},{"_id":4,"slug":4,"title":5,"subtitle":6,"cover":8,"tech_type":9,"indications":10,"official_price":11,"hospital_name":12,"hospital_names":13,"tech_company_name":12,"view_count":14,"favorite_count":15,"is_favorite":16,"approval_no":17,"approval_date":18,"regulatory_level":19,"valid_until":18,"filing_date":18,"intro":20,"detail_desc":21,"target_population":22,"compliance_list":23,"process":24},"6bdc73f469ef5fe100da5d634c842ea6","RPE65 双等位基因突变相关遗传性视网膜营养不良的基因应用",[7],"遗传性视网膜病变","https://6875-huali-cell-8geyb3yje6a285d1-1419749029.tcb.qcloud.la/assets/cover/1779099648582-007RPE65双等位基因突变相关的遗传性视网膜营养不良的基因治疗.jpg","基因应用",[7],"48万/单眼","朗信启昇生物制药有限公司",[],34,1,false,"乐城第二批获批","","中高风险","\u003Cp>AAV 载体介导 RPE65 基因功能性拷贝向视网膜色素上皮的递送,用于遗传性视网膜营养不良。\u003C/p>\u003Cp>\u003Cb>适应症\u003C/b>:RPE65 双等位基因突变视网膜病变\u003Cbr/>\u003Cb>技术类型\u003C/b>:基因应用\u003Cbr/>\u003Cb>批次\u003C/b>:乐城第二批获批\u003C/p>","AAV 载体介导 RPE65 基因功能性拷贝向视网膜色素上皮的递送,用于遗传性视网膜营养不良。",[],[],[],1779368115444]